Navigation Links
New Blood Test To Detect Iron Level In Infants

A new blood test is all set to measure the iron deficiency in infants earlier than other blood tests, reports the recent issue of the Journal of the American Medical Association.

Iron deficiency is estimated to affect nearly 10 percent // of children of one to two years of age. Early detection and treatment are critical because iron deficiency can impair infant mental development, possibly permanently, even before it progresses to anemia (clinically identified as a low hemoglobin level).

The study, done at Children’s Hospital Boston, is the first to compare the test, called CHr, with the standard hemoglobin test as a screen for iron deficiency in infants. Hemoglobin is the iron-containing, oxygen-carrying molecule in red blood cells; the CHr test measures the hemoglobin content of reticulocytes, or immature red blood cells, whereas the standard hemoglobin test is based on the entire population of red blood cells.

Because reticulocytes are present in the bloodstream for only 24 to 48 hours, as compared with several months for mature red blood cells, measuring the reticulocyte hemoglobin content (i.e., CHr) provides a more timely indication of iron status, the investigators say.

In this study, 200 healthy infants 9 to 12 months of age underwent both tests, as well as a transferrin saturation test, which is the “gold standard” test for iron deficiency but is impractical for routine screening. Using the optimal CHr cutoff value (established as 27.5 picograms), CHr correctly identified 83 percent of the iron-deficient infants, compared with only 26 percent identified by the current screening standard (a hemoglobin level less than 11 grams/deciliter).

This study shows that CHr can be used to detect iron deficiency earlier and more accurately than standard hemoglobin screening. Once confirmed in larger, multicenter studies, these findings could change the preferred screening practices for the early detection of iron deficiency. The researchers had said that the CHr test is simple, requires no extra tubes of blood to be drawn and involves no additional cost.

Source: Newswise
'"/>




Related medicine news :

1. Recommendations for Treatment of Blood Pressue
2. Blood Cells Capable of Regenerating Liver
3. Blood clots likely in long travel
4. Hemochromatosis Patients Blood is Safe
5. Blood transfusions beneficial after heart attacks
6. Blood Pressure Drug may slow wasting in burn victims
7. Levels Of Blood Proteins May Help Heart Disease Care
8. Blood test may identify ovarian cancer
9. A Blood test for suicide risk?
10. Blood Pressure Drugs maintain muscle strength
11. Blood test diagnoses heart failure in short time
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: